CO2021005679A2 - Composiciones que comprenden celulosa oxidada - Google Patents
Composiciones que comprenden celulosa oxidadaInfo
- Publication number
- CO2021005679A2 CO2021005679A2 CONC2021/0005679A CO2021005679A CO2021005679A2 CO 2021005679 A2 CO2021005679 A2 CO 2021005679A2 CO 2021005679 A CO2021005679 A CO 2021005679A CO 2021005679 A2 CO2021005679 A2 CO 2021005679A2
- Authority
- CO
- Colombia
- Prior art keywords
- glycerol
- compositions
- less
- adhesion prevention
- oxidized cellulose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/06—Use of macromolecular materials
- A61L33/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0042—Materials resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/009—Materials resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0047—Enzymes, e.g. urokinase, streptokinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/424—Anti-adhesion agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Medicinal Chemistry (AREA)
- Materials Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención proporciona composiciones comprendidas por celulosa oxidada (OC) y glicerol, con la relación de glicerol a OC de al menos aproximadamente 0,5:1 p/p de glicerol:OC y/o con la viscosidad de la composición al menos 10 % mayor que la del glicerol y menor que aproximadamente 2,6X109 cP, con el contenido 5 total de agua menor que aproximadamente 8 % p/p. Además, se proporciona un polvo para la prevención de adhesión comprendido de OC que tiene un contenido de carboxilo igual a menor que 18 %, caracterizado por una alta potencia de prevención de adhesión. Además, en la presente descripción se proporcionan usos de las composiciones como hemostáticos o como material 10 de prevención de adhesión, y métodos para la preparación de estas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862753981P | 2018-11-01 | 2018-11-01 | |
IL262716A IL262716A (en) | 2018-11-01 | 2018-11-01 | Oxidized cellulose preparations |
PCT/IL2019/000003 WO2020089883A2 (en) | 2018-11-01 | 2019-10-30 | Compositions comprising oxidized cellulose |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2021005679A2 true CO2021005679A2 (es) | 2021-05-10 |
Family
ID=66624699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2021/0005679A CO2021005679A2 (es) | 2018-11-01 | 2021-04-29 | Composiciones que comprenden celulosa oxidada |
Country Status (13)
Country | Link |
---|---|
US (2) | US20200139021A1 (es) |
EP (3) | EP4327840A3 (es) |
JP (2) | JP2022509912A (es) |
KR (1) | KR20210089694A (es) |
CN (2) | CN112969481A (es) |
AU (1) | AU2019373895A1 (es) |
BR (1) | BR112021008297A2 (es) |
CA (1) | CA3117353A1 (es) |
CO (1) | CO2021005679A2 (es) |
ES (1) | ES2967597T3 (es) |
IL (1) | IL262716A (es) |
MX (1) | MX2021005146A (es) |
WO (2) | WO2020089883A2 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11739166B2 (en) | 2020-07-02 | 2023-08-29 | Davol Inc. | Reactive polysaccharide-based hemostatic agent |
WO2022217492A1 (en) | 2021-04-14 | 2022-10-20 | Guangzhou Bioseal Biotech Co., Ltd. | Flowable hemostatic paste |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3122479A (en) * | 1957-11-14 | 1964-02-25 | David F Smith | Hemostatic surgical dressings |
US3364200A (en) | 1960-03-28 | 1968-01-16 | Johnson & Johnson | Oxidized cellulose product and method for preparing the same |
US4668224A (en) * | 1983-10-24 | 1987-05-26 | Warner-Lambert Company | Oxidized cellulose as a medical lubricant |
US4626253A (en) | 1984-10-05 | 1986-12-02 | Johnson & Johnson Products, Inc. | Surgical hemostat comprising oxidized cellulose |
US5007916A (en) | 1985-08-22 | 1991-04-16 | Johnson & Johnson Medical, Inc. | Method and material for prevention of surgical adhesions |
US5002551A (en) | 1985-08-22 | 1991-03-26 | Johnson & Johnson Medical, Inc. | Method and material for prevention of surgical adhesions |
US4696812A (en) * | 1985-10-28 | 1987-09-29 | Warner-Lambert Company | Thrombin preparations |
US5134229A (en) * | 1990-01-12 | 1992-07-28 | Johnson & Johnson Medical, Inc. | Process for preparing a neutralized oxidized cellulose product and its method of use |
US5180398A (en) | 1990-12-20 | 1993-01-19 | Johnson & Johnson Medical, Inc. | Cellulose oxidation by a perfluorinated hydrocarbon solution of nitrogen dioxide |
US5266624A (en) * | 1992-07-20 | 1993-11-30 | Isp Investments Inc. | High load polymer pastes as pharmaceutical adhesives |
US5696101A (en) * | 1996-04-16 | 1997-12-09 | Eastman Chemical Company | Oxidized cellulose and vitamin E blend for topical hemostatic applications |
US20030073663A1 (en) * | 1997-06-25 | 2003-04-17 | David M Wiseman | Bioabsorbable medical devices from oxidized polysaccharides |
US6627749B1 (en) * | 1999-11-12 | 2003-09-30 | University Of Iowa Research Foundation | Powdered oxidized cellulose |
AU784607B2 (en) * | 2000-05-12 | 2006-05-11 | Systagenix Wound Management Ip Co. B.V. | Free radical scavenging compositions |
JP2003024431A (ja) * | 2001-07-18 | 2003-01-28 | Kuraray Co Ltd | 癒着防止材およびその製造方法 |
EP1601388B1 (en) * | 2003-03-10 | 2011-04-27 | Johnson & Johnson Medical Ltd. | Hydrocolloid materials for use in wound healing |
US20040265371A1 (en) | 2003-06-25 | 2004-12-30 | Looney Dwayne Lee | Hemostatic devices and methods of making same |
CA2539568C (en) * | 2003-09-23 | 2013-09-10 | Orthotherapeutics, Llc | Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects |
US7109163B2 (en) * | 2004-01-30 | 2006-09-19 | Ethicon, Inc. | Hemostatic compositions and devices |
WO2006006140A1 (en) * | 2004-07-08 | 2006-01-19 | Alltracel Development Services Limited | A delivery system for control bleeding skin wounds |
JP5399891B2 (ja) * | 2006-03-13 | 2014-01-29 | エリオット・キャピタル・インベストメンツ・ザ・サード・リミテッド | 酸化微生物セルロースおよびその使用 |
CN104888263B (zh) * | 2008-01-14 | 2018-11-30 | 北京环球利康科技有限公司 | 生物相容性止血、防粘连、促愈合、外科封闭的变性淀粉材料 |
US9572907B2 (en) | 2010-10-01 | 2017-02-21 | Covidien Lp | Implantable polymeric films |
US20130084324A1 (en) * | 2011-09-30 | 2013-04-04 | Michel Gensini | Adhesion prevention fabric |
ES2938566T3 (es) * | 2011-10-11 | 2023-04-12 | Baxter Int | Composiciones hemostaticas |
US8815832B2 (en) * | 2012-05-25 | 2014-08-26 | Ethicon, Inc. | Oxidized regenerated cellulose hemostatic powders and methods of making |
US9447196B2 (en) | 2012-06-28 | 2016-09-20 | Covidien Lp | Dissolution of oxidized cellulose and particle preparation by solvent and non-solvent precipitation |
CU20170107A7 (es) | 2015-02-16 | 2018-07-05 | Petro Andriyovych Manoryk | Composición hemostática y dispositivo hemostático (variantes) |
US10172617B2 (en) * | 2015-03-25 | 2019-01-08 | Ethicon Llc | Malleable bioabsorbable polymer adhesive for releasably attaching a staple buttress to a surgical stapler |
BR112018008895B1 (pt) | 2015-11-06 | 2021-11-16 | Ethicon, Inc. | Agregados hemostáticos e método para sua produção |
MX2018005784A (es) * | 2015-11-08 | 2018-11-29 | Omrix Biopharmaceuticals Ltd | Mezcla hemostatica de fibras cortas y largas basadas en celulosa. |
CN105536039A (zh) * | 2015-12-25 | 2016-05-04 | 北京大清生物技术有限公司 | 一种可吸收流体止血材料及其制备方法与应用 |
WO2018049059A1 (en) * | 2016-09-07 | 2018-03-15 | Blood Brothers, LLC | Hemostatic paste with light-curable feature |
-
2018
- 2018-11-01 IL IL262716A patent/IL262716A/en unknown
-
2019
- 2019-10-30 KR KR1020217016577A patent/KR20210089694A/ko unknown
- 2019-10-30 EP EP23210952.0A patent/EP4327840A3/en active Pending
- 2019-10-30 AU AU2019373895A patent/AU2019373895A1/en active Pending
- 2019-10-30 MX MX2021005146A patent/MX2021005146A/es unknown
- 2019-10-30 WO PCT/IL2019/000003 patent/WO2020089883A2/en active Application Filing
- 2019-10-30 ES ES19806061T patent/ES2967597T3/es active Active
- 2019-10-30 CA CA3117353A patent/CA3117353A1/en active Pending
- 2019-10-30 EP EP19806061.8A patent/EP3873548B1/en active Active
- 2019-10-30 JP JP2021523733A patent/JP2022509912A/ja active Pending
- 2019-10-30 BR BR112021008297-2A patent/BR112021008297A2/pt unknown
- 2019-10-30 US US16/668,691 patent/US20200139021A1/en active Pending
- 2019-10-30 CN CN201980072743.0A patent/CN112969481A/zh active Pending
-
2020
- 2020-05-05 US US16/866,739 patent/US20200261492A1/en active Pending
-
2021
- 2021-04-29 CO CONC2021/0005679A patent/CO2021005679A2/es unknown
- 2021-05-03 EP EP21727946.2A patent/EP4146294A1/en active Pending
- 2021-05-03 CN CN202180033290.8A patent/CN115515654A/zh active Pending
- 2021-05-03 WO PCT/IL2021/050513 patent/WO2021224919A1/en unknown
- 2021-05-03 JP JP2022567307A patent/JP2023524137A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
IL262716A (en) | 2018-11-29 |
EP3873548A2 (en) | 2021-09-08 |
WO2020089883A2 (en) | 2020-05-07 |
EP3873548B1 (en) | 2023-11-29 |
BR112021008297A2 (pt) | 2021-08-03 |
US20200139021A1 (en) | 2020-05-07 |
EP4327840A2 (en) | 2024-02-28 |
EP3873548C0 (en) | 2023-11-29 |
ES2967597T3 (es) | 2024-05-03 |
US20200261492A1 (en) | 2020-08-20 |
JP2022509912A (ja) | 2022-01-25 |
KR20210089694A (ko) | 2021-07-16 |
AU2019373895A1 (en) | 2021-05-20 |
WO2020089883A3 (en) | 2020-06-18 |
EP4327840A3 (en) | 2024-05-22 |
CA3117353A1 (en) | 2020-05-07 |
JP2023524137A (ja) | 2023-06-08 |
CN112969481A (zh) | 2021-06-15 |
WO2021224919A1 (en) | 2021-11-11 |
EP4146294A1 (en) | 2023-03-15 |
MX2021005146A (es) | 2021-07-15 |
CN115515654A (zh) | 2022-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2017001488A1 (es) | Benzamidas sustituidas con 1,3–tiazol–2–ilo | |
CO2021005679A2 (es) | Composiciones que comprenden celulosa oxidada | |
BR112015019657A2 (pt) | composições tópicas e métodos de uso das mesmas | |
UY38382A (es) | Agentes de arni para inhibir la expresión de 17beta-hsd tipo 13 (hsd17b13), composiciones de dichos agentes, y métodos de uso | |
CY1113449T1 (el) | Αντι-ιικες συνθεσεις που περιλαμβανουν γερανιολη και καρβονη | |
AR107967A1 (es) | Ácido hialurónico modificado, método para su preparación y usos del mismo | |
BR112019001054A2 (pt) | desinfetantes tópicos emolientes | |
AR077199A1 (es) | Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia | |
GT201400043A (es) | Imidazopiridazinas sustituidas con amino | |
BR112014016668A8 (pt) | composições para cuidados pessoais contendo silicone iônico e agente formador de filme | |
BR112014026118A2 (pt) | métodos relacionados a composições para cuidados pessoais | |
UY36703A (es) | Composiciones y métodos para la administración de un polinucleótido en una planta | |
CL2020000220A1 (es) | Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial. | |
AR094012A1 (es) | Composiciones estables con peroxido para el cuidado oral | |
DOP2016000007A (es) | Pirazolpiridinas sustituidas | |
AR101236A1 (es) | Composiciones para el cuidado oral | |
BR112016017897A8 (pt) | uso de composto de carboxamida heterocíclica de diamino no tratamento de câncer relacionado ao axl, composição farmacêutica e combinação | |
PE20191044A1 (es) | Composicion farmaceutica | |
NI201900063A (es) | Amidas aromáticas de ácido carboxílico | |
BR112017010453A2 (pt) | composição adesiva com mudança de cor | |
BR112017020594A2 (pt) | composição para o auxílio ao barbear, cartucho de lâmina e utilização de uma mistura | |
BR112014012885A2 (pt) | composição de gel celulósica com estabilidade de viscosidade aperfeiçoada | |
MY177028A (en) | Solid compositions of triglycerides and uses thereof | |
UY38982A (es) | Composiciones farmacéuticas | |
BR112015032853A2 (pt) | produto de tratamento oral e método de remineralização de dente |